Blueprint

“We probably will not do physical clinics. It's just too much on the real estate. And so, but we'll probably license it out. We'll probably do the digital model.”

“Basically, somebody's gonna set up shop in longevity and ride a multi-trillion dollar ride. So that's what we're trying to do, is we're trying to just be home base, win the early innings of longevity, and then ride for the multi-trillion dollar market.”

“Our health will be run on our behalf. So right now we have to chase down all our food, we have to chase down protocols, we have to chase down evidence, but it's not going to be that in the future. It will be that it will just be run for us.”

“We have about a dozen groups around the world that want to stand this up, and some of the biggest hotel chains around the world.”

“We will build an infrastructure to basically, when you want a prescription, if you want to go on a GLP-ONE, we can help you get started. Whether you want a large dose or a micro dose,”

“What a lot of people don't realize is this endeavor is entirely about AI alignment.”

“When we test organic, It typically performs worse than non-organic on many, many variables.”

“So for me, over the past five years, we are counting yesterday we have a few billion data points on me over the past five years. And so, then if you say, what of those few billion data points are usable? Probably a few hundred million.”

“I think that we will exceed them in value in many core areas. Because they, you, they can take, you know, well-structured, well-funded clinical trials. But then other things like peptides that are very promising. They're not going to have the clinical work.”

“We are going to deliver autonomous health. And so like there's self-driving cars, there's self-writing software. This is autonomous health. So we're building AI that just says do this.”

“Our goal is to create the world's largest data set across all these sectors. And then you basically can create an ecosystem where the person could be paid for their data. So they collect the data, they're starting to the experimentation. Companies come in and …”

“So it's called Immortals. A million dollars a year. And it's my exact protocol. So my doctors, my concierge team, all the testing infrastructure.”